Gaia, which helps individuals and couples manage the high costs of in vitro fertilization (IVF) treatments, has secured additional funding in a round led by Valar Ventures.
The investment will support the company, which in alongside IVF services offers egg donation, egg freezing and embryo batching, to further expand across the United States.
Originally founded in the UK in 2019, InsurTech Corridor participant Gaia currently operates in 57 locations across 23 clinic groups in the US, serving a market where IVF treatment cycles cost on average between $15,000 and $25,000, with success rates ranging from 25% to 40%.
Founder and CEO Nader AlSalim’s personal journey inspired Gaia’s mission. After enduring years of challenging fertility treatments across multiple clinics and countries, he and his wife welcomed their son. This experience motivated him to create Gaia, aiming to make fertility treatments more financially manageable.
The company offers personalized financial plans that cover multiple IVF cycles, allowing users to pay in instalments and providing refunds if treatments are unsuccessful. By using data-driven predictions, Gaia aims to make fertility treatments more accessible and reduce financial risks for patients.
